Jetema

제테마 · 216080

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$131.3M (₩181.2B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$55.7M
▲ +12.2% YoY
Operating profit · FY2025
US$2.8M
▼ −7.1% YoY
Net income · FY2025
−US$5.4M
Loss widened

Revenue

  • FY2023US$42.5M
  • FY2024US$49.7M
  • FY2025US$55.7M

Operating profit

  • FY2023US$1.9M
  • FY2024US$3M
  • FY2025US$2.8M

Net income

  • FY2023US$9.9M
  • FY2024−US$1.9M
  • FY2025−US$5.4M

Key ratios (FY2025)

ROE
-11.4%
Debt/Eq
221.7%
Op. margin
5.0%
Net margin
-9.7%
Rev. YoY
▲ +12.2%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.